BCAPS
Beta-blocker Cholesterol-lowering Asymptomatic Plaque Study

Purpose
To investigate the effect of fluvastatin or metoprolol CR on the progression rate of signs of early carotid atherosclerotic lesions

References
Dr B Hedblad: Beta-blocker cholesterol-lowering asymptomatic plaque study (BCAPS). Baseline results and intima-media thickness progression rate. European Atherosclerosis Society 1996:109.

Voltar

Apoio: Libbs Farmacêutica Farmacêutica